A physician-scientist, her groundbreaking work in vascular and lung engineering has made Dr. Niklason a world leader in regenerative medicine. She is a member of the National Academies of Engineering and Medicine. Dr. Niklason is the founder of Humacyte and has served as President and Chief Executive Officer since November 2020 and as a member of the Humacyte Board since 2004. Dr. Niklason holds a Ph.D. in Biophysics from the University of Chicago and an M.D. from the University of Michigan.
Fler avsnitt av Biotech 2050 Podcast
Visa alla avsnitt av Biotech 2050 PodcastBiotech 2050 Podcast med Biotech 2050 finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
